Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

The Food and Drug Administration (FDA) has expanded the approval of Furoscix® (furosemide injection) to include the treatment of edema in patients with ...

Edema, or fluid retention, does not always require treatment. However, a doctor will address any underlying causes and may prescribe medications such as furosemide or heparin to reduce fluids in ...